Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
EJNMMI Research|May 22, 2013
99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic modelElisabeth Miot-Noirault, Emmanuelle David, Aurélien Vidal, et al.
ACS Medicinal Chemistry Letters|February 21, 2015
Development and Preliminary Evaluation of TFIB, a New Bimodal Prosthetic Group for Bioactive Molecule LabelingEmilie M F Billaud, Aurélien Vidal, Amélie Vincenot, et al.
European Journal of Medicinal Chemistry|September 20, 2011
New aldehyde and vinylsulfone proteasome inhibitors for targeted melanoma therapyMagali Vivier, Maryse Rapp, Marie-Josephe Galmier, et al.
Pharmaceuticals (Basel, Switzerland)|April 26, 2016
Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in BrainJianrong Liu, Barbara Wenzel, Sladjana Dukic-Stefanovic, et al.
Bioorganic Chemistry|March 26, 2020
Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapyYvain Gerard, Aurélien Voissière, Caroline Peyrode, et al.
European Journal of Medicinal Chemistry|July 20, 2020
Optimization of IEDDA bioorthogonal system: Efficient process to improve trans-cyclooctene/tetrazine interactionJean-Baptiste Béquignat, Nancy Ty, Aurélie Rondon, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
A Convenient Route to New (Radio)Fluorinated and (Radio)Iodinated Cyclic Tyrosine AnalogsMaria Noelia Chao, Jean-Michel Chezal, Eric Debiton, et al.
Investigational New Drugs|June 23, 2010
Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitterMaryline Gardette, Janine Papon, Mathilde Bonnet, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 12, 2016
Preparation of core/shell NaYF4:Yb,Tm@dendrons nanoparticles with enhanced upconversion luminescence for in vivo imagingNadège Francolon, Damien Boyer, Felicia Leccia, et al.
Investigational New Drugs|April 19, 2011
Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studiesCaroline Peyrode, Valérie Weber, Emmanuelle David, et al.
Pageof 9